<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Breast pain</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Breast pain</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Breast pain</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Mehra Golshan, MD, MBA, FACS</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Anees B Chagpar, MD, MSc, MA, MPH, MBA, FACS, FRCS(C)</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Wenliang Chen, MD, PhD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Apr 04, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Breast pain (mastalgia) is common in women and occasionally occurs in men. Although it is usually mild and self-limited, approximately 15 percent of affected women require treatment [<a href="#rid1">1</a>]. Evaluation of breast pain is important to determine whether the pain is due to normal physiological changes related to hormonal fluctuation or to a pathologic process such as breast cancer. Unfortunately, studies specific to breast pain are limited and often small in number, not well designed, and with limited follow-up.</p><p>Breast pain is a rare symptom of breast cancer. Women who present with breast pain but who have a normal examination and imaging studies can be reasonably assured that their risk of breast cancer is similar to that of a woman without breast pain. Most patients do not seek further medical attention for the pain once they are assured that they do not have breast cancer.</p><p>While cyclical breast pain has traditionally been attributed to fibrocystic changes, chronic cystic mastitis, and mammary dysplasia [<a href="#rid2">2-4</a>], breast pain and nodularity are so common that the term fibrocystic "disease" has become obsolete, and we suggest that it no longer be used, although it is commonly used by the patient at presentation. </p><p>This topic will discuss the etiology, evaluation, and treatment of breast pain in women  (<a class="graphic graphic_algorithm graphicRef117756" href="/z/d/graphic/117756.html" rel="external">algorithm 1</a>). Evaluation of a breast mass or cancer is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/804.html" rel="external">"Clinical manifestations, differential diagnosis, and clinical evaluation of a palpable breast mass"</a> and  <a class="medical medical_review" href="/z/d/html/808.html" rel="external">"Diagnostic evaluation of suspected breast cancer"</a>.)</p><p>Breast pain caused by inflammatory or infectious etiologies (ie, mastitis) is discussed in other topics. (See  <a class="medical medical_review" href="/z/d/html/798.html" rel="external">"Lactational mastitis"</a> and  <a class="medical medical_review" href="/z/d/html/794.html" rel="external">"Nonlactational mastitis in adults"</a> and  <a class="medical medical_review" href="/z/d/html/795.html" rel="external">"Primary breast abscess"</a> and  <a class="medical medical_review" href="/z/d/html/797.html" rel="external">"Breast cellulitis and other skin disorders of the breast"</a>.)</p><p>In addition, pain that develops after breast surgery is of a different etiology and is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/14973.html" rel="external">"Clinical manifestations and diagnosis of postmastectomy pain syndrome"</a> and  <a class="medical medical_review" href="/z/d/html/86609.html" rel="external">"Postmastectomy pain syndrome: Risk reduction and management"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Breast pain is common; up to 70 percent of women in Western societies will experience it sometime during their lives [<a href="#rid5">5</a>]. One study of almost 1700 women (mean age 34 years) surveyed by online questionnaire found that over one-half (51.5 percent) had experienced breast pain [<a href="#rid6">6</a>]. Pain was more commonly reported among older women, those with larger breast sizes, and those less fit and/or physically active. In addition, of those who reported symptoms, 41 and 35 percent reported negative impacts from breast pain on their sexual health and sleep, respectively. Ten percent of those symptomatic had reported breast pain as an issue for over half of their lives.</p><p>Although not as well studied and characterized, the prevalence of breast pain appears to depend on the population studied. As an example, breast pain is less common in Asian societies, affecting as few as 5 percent of women [<a href="#rid7">7</a>]. </p><p class="headingAnchor" id="H4"><span class="h1">CLASSIFICATION AND ETIOLOGY</span><span class="headingEndMark"> — </span>Breast pain can be classified into three categories: cyclical, noncyclical, and extramammary [<a href="#rid8">8</a>]. Clinically it is more important to differentiate between extramammary and true breast pain than between cyclical and noncyclical pain [<a href="#rid9">9</a>]. This is because the management of cyclical and noncyclical breast pain is similar, while extramammary pain may require a different treatment  (<a class="graphic graphic_algorithm graphicRef117756" href="/z/d/graphic/117756.html" rel="external">algorithm 1</a>). (See <a class="local">'Extramammary pain'</a> below.)</p><p class="headingAnchor" id="H5"><span class="h2">Cyclical breast pain</span><span class="headingEndMark"> — </span>Cyclical pain affects two-thirds of patients with true mastalgia. Cyclical pain is associated with hormonal fluctuations of the menstrual cycle, usually presenting in the week prior to onset of menses. It is frequently bilateral and most severe in the upper outer quadrant of the breasts.</p><p>Minor cyclical breast discomfort is normal; it begins during the late luteal phase and dissipates with the onset of menses. This is usually bilateral and diffuse pain, sometimes radiating toward the upper outer quadrant. Cyclical breast discomfort is caused by normal hormonal changes associated with ovulation that stimulate the proliferation of normal glandular breast tissue and result in pain. The stimulation of ductal elements by estrogen, stimulation of the stroma by progesterone, and/or stimulation of ductal secretion by prolactin all contribute to cyclical pain during the menstrual cycle. Cyclical breast pain can also be associated with pharmacologic hormonal agents (eg, postmenopausal hormone therapy or oral contraceptive pills). </p><p class="headingAnchor" id="H6"><span class="h2">Noncyclical breast pain</span><span class="headingEndMark"> — </span>Noncyclical pain affects up to one-third of women with true mastalgia. The pain does not follow the usual menstrual pattern, may be constant or intermittent, and is more likely to be unilateral and variable in its location in the breast. Noncyclical breast pain is more likely to be related to a breast or chest wall lesion. Possible etiologies include:</p><p class="bulletIndent1"><span class="glyph">●</span>Large pendulous breasts – Large pendulous breasts may cause pain due to stretching of Cooper's ligaments. Neck, back, and shoulder pain and headache may be present, as well as a rash under the pendulous breast in the inframammary fold. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Diet, lifestyle – The role of diet and lifestyle in causing breast pain is uncertain. Although a high-fat diet [<a href="#rid10">10,11</a>], smoking [<a href="#rid12">12-14</a>], and caffeine intake have been associated with breast pain, it is difficult to conduct randomized trials with appropriate blinding that will negate the placebo effect. Hence, there is currently no high-quality evidence to suggest that a low-fat diet, smoking cessation, or caffeine avoidance reduces breast pain. (See <a class="local">'Therapies not proven by randomized trial data'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hormone replacement therapy – Up to one-third of menopausal women receiving postmenopausal hormone therapy experience some degree of noncyclical breast pain, which may spontaneously resolve over time [<a href="#rid15">15-17</a>]. (See  <a class="medical medical_review" href="/z/d/html/7427.html" rel="external">"Menopausal hormone therapy: Benefits and risks"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Breast cysts – Solitary cysts, particularly when the presentation is with rapid onset, are frequently painful. (See  <a class="medical medical_review" href="/z/d/html/799.html" rel="external">"Breast cysts: Clinical manifestations, diagnosis, and management"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Ductal ectasia – Ductal ectasia is characterized by distention of subareolar ducts due to inflammation unrelated to infection. Ductal ectasia may be associated with fever and acute local pain and tenderness caused by penetration of the duct wall by lipid material, which may resolve to leave a subareolar nodule. In one study, the site and degree of duct dilatation correlated with the intensity of noncyclical breast pain [<a href="#rid18">18</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Mastitis – Mastitis or breast abscess typically presents as a painful, swollen, and red breast in a febrile woman. Mastitis is more prevalent during lactation but can also occur in nonlactating women (eg, idiopathic granulomatous mastitis [IGM]) and/or smokers. The diagnosis and treatment of mastitis are discussed separately. The rest of this topic assumes that mastitis has been excluded by physical examination. (See  <a class="medical medical_review" href="/z/d/html/798.html" rel="external">"Lactational mastitis"</a> and  <a class="medical medical_review" href="/z/d/html/794.html" rel="external">"Nonlactational mastitis in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Inflammatory breast cancer – Women with de novo inflammatory breast cancer (primary disease) may present with pain and a rapidly progressing tender, firm, enlarged breast. The skin over the breast is warm and thickened, with a "peau d'orange" (orange skin) appearance, but there is often no fever or leukocytosis  (<a class="graphic graphic_picture graphicRef70894" href="/z/d/graphic/70894.html" rel="external">picture 1</a> and <a class="graphic graphic_picture graphicRef82220" href="/z/d/graphic/82220.html" rel="external">picture 2</a>). (See  <a class="medical medical_review" href="/z/d/html/768.html" rel="external">"Inflammatory breast cancer: Clinical features and treatment"</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hidradenitis suppurativa – Hidradenitis suppurativa, although primarily confined to the axilla, can involve the breast and present as breast nodules, drainage, and pain. (See  <a class="medical medical_review" href="/z/d/html/5575.html" rel="external">"Hidradenitis suppurativa: Pathogenesis, clinical features, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Other – Other etiologies of breast pain include pregnancy, thrombophlebitis (Mondor's disease), trauma, macrocysts, prior breast surgery, and a variety of medications (hormones as well as some antidepressants, cardiovascular agents, and antibiotics) [<a href="#rid19">19</a>].</p><p></p><p class="headingAnchor" id="H7"><span class="h2">Extramammary pain</span><span class="headingEndMark"> — </span>Some women who present with breast pain actually have referred pain from sources other than the breasts. The breast is innervated by the anterolateral and anteromedial branches of the intercostal nerves (T3 to T5), and irritation of these nerves anywhere along their course can lead to pain that is felt in the breast or nipple [<a href="#rid9">9</a>]. In some studies done in primary care and certain breast clinic settings, it has been found that women presenting with breast pain more often have extramammary pain rather than true mastalgia [<a href="#rid9">9</a>]. </p><p>Extramammary pain may be from musculoskeletal sources such as the chest wall, spinal or paraspinal disorders, trauma, or scarring from prior biopsy. It may also be related to medical problems such as biliary, pulmonary, esophageal, or cardiac disease.</p><p class="bulletIndent1"><span class="glyph">●</span>Chest wall pain – Chest wall pain is frequently due to pectoralis major muscle injury, related to repetitive activities such as water skiing, raking, rowing, or shoveling. Chest wall pain that presents as bilateral parasternal discomfort can also arise from costochondritis (typically the second through fifth costochondral junctions) or Tietze syndrome (typically the second and third costochondral junctions). Other etiologies of chest wall pain include slipping and clicking ribs and arthritis. (See  <a class="medical medical_review" href="/z/d/html/5622.html" rel="external">"Major causes of musculoskeletal chest pain in adults", section on 'Isolated musculoskeletal chest pain syndromes'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Spinal and paraspinal disorders – Radicular chest wall pain may be due to cervical arthritis. This pain typically occurs in older women in whom vertebral, spinal, and paraspinal problems in the neck and upper thorax accumulate with age. Paraspinal muscle spasm and other impingements on the free course of the sensory nerves from the neck and upper thorax can cause a radiculopathy leading to pain or hyperesthesia. Burning pain, which is typical of nerve root pressure, is a common feature. Imaging studies of the neck may reveal the etiology of the pain. (See  <a class="medical medical_review" href="/z/d/html/5271.html" rel="external">"Clinical features and diagnosis of cervical radiculopathy"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Trauma – Breast pain can be caused by local trauma, such as seat belt injury, child or pet, or intimate partner violence, to the breasts or anterior chest wall. Pain can also be caused by intercostal neuralgia due to a respiratory infection or underlying pleuritic lesions. Additionally, gallbladder disease or ischemic heart disease may present as intermittent chest pain attributed to the breast.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Postthoracotomy syndrome is an unusual disorder in which a healing chest wound simulates the effect of a suckling infant. It can be associated with an elevated prolactin concentration, breast pain, and milk production. A similar effect can be seen with other forms of chest wall irritation, including burns and chafing from clothing overlying the nipple [<a href="#rid20">20</a>].</p><p></p><p class="headingAnchor" id="H8"><span class="h1">HISTORY</span><span class="headingEndMark"> — </span>It may be helpful to ask women with cyclical pain to record the occurrence and severity of breast pain in a diary and note potential aggravating and ameliorating factors. Questions the patient should be asked about her pain include:</p><p class="bulletIndent1"><span class="glyph">●</span>Where in the breast or axilla does the pain occur?</p><p class="bulletIndent1"><span class="glyph">●</span>Is the pain bilateral?</p><p class="bulletIndent1"><span class="glyph">●</span>What does the pain feel like?</p><p class="bulletIndent1"><span class="glyph">●</span>How severe is the pain?</p><p class="bulletIndent1"><span class="glyph">●</span>If premenopausal: is it phasic, with peaks at midcycle and premenstrually?</p><p class="bulletIndent1"><span class="glyph">●</span>Is it associated with use of oral contraceptive pills or hormone replacement therapy?</p><p class="bulletIndent1"><span class="glyph">●</span>Did it begin after a recent birth or pregnancy loss or termination?</p><p class="bulletIndent1"><span class="glyph">●</span>Is it related to vigorous or repetitive use of the pectoral muscle group?</p><p class="bulletIndent1"><span class="glyph">●</span>Is there a concurrent neck, back, or shoulder problem?</p><p class="bulletIndent1"><span class="glyph">●</span>Are there systemic or other local symptoms, such as fever or erythema?</p><p class="bulletIndent1"><span class="glyph">●</span>Is there a history of recent trauma to the chest?</p><p class="bulletIndent1"><span class="glyph">●</span>Does the pain affect her ability to perform daily activities?</p><p></p><p>In addition, a complete medical and surgical history and systematic review of systems should be obtained. Breast cancer risk should be assessed. (See  <a class="medical medical_review" href="/z/d/html/7564.html" rel="external">"Screening for breast cancer: Strategies and recommendations", section on 'Breast cancer risk determination'</a>.)</p><p>Chest wall pain is often lateral and may be burning or knifelike, and localized or diffuse. (See  <a class="medical medical_review" href="/z/d/html/5622.html" rel="external">"Major causes of musculoskeletal chest pain in adults"</a>.)</p><p class="headingAnchor" id="H9"><span class="h1">PHYSICAL EXAMINATION</span></p><p class="headingAnchor" id="H3271184371"><span class="h2">Breast</span><span class="headingEndMark"> — </span>The breast should be examined for signs of inflammation or infection, which would suggest an etiology of mastitis. Mastitis typically presents as a painful, swollen, and red breast in a febrile woman. Mastitis is more prevalent during lactation but can also occur in nonlactating women. The diagnosis and treatment of mastitis is discussed separately. The rest of this topic assumes that mastitis has been excluded by physical examination. (See  <a class="medical medical_review" href="/z/d/html/798.html" rel="external">"Lactational mastitis", section on 'Clinical manifestations'</a> and  <a class="medical medical_review" href="/z/d/html/794.html" rel="external">"Nonlactational mastitis in adults", section on 'Clinical manifestations'</a>.)</p><p>The key point in examining a woman with breast pain is to look for signs suggestive of breast malignancy, such as a mass, skin changes, or bloody nipple discharge. (See  <a class="medical medical_review" href="/z/d/html/804.html" rel="external">"Clinical manifestations, differential diagnosis, and clinical evaluation of a palpable breast mass"</a> and  <a class="medical medical_review" href="/z/d/html/802.html" rel="external">"Nipple discharge"</a>.)</p><p>The four breast quadrants, subareolar areas, axillae, and supraclavicular and infraclavicular areas should be systematically examined with the woman both lying and sitting with her hands on her hips and then above her head. The specific goals of the examination are to:</p><p class="bulletIndent1"><span class="glyph">●</span>Check for skin changes, noting the symmetry and contour of the breasts, position of the nipples, scars, skin retraction, dimpling, edema or erythema, ulceration or crusting of the nipple, and changes in skin color</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Check for enlarged or tender axillary, supraclavicular, or infraclavicular lymph nodes</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Delineate and document breast masses</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Check for nipple discharge</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Identify localized areas of tenderness and relate them to areas of pain noted by the woman and to other physical findings</p><p></p><p>Women found to have a palpable breast mass, skin changes, or bloody nipple discharge should be referred to a breast specialist for further evaluation and imaging to treat or exclude breast cancer. (See  <a class="medical medical_review" href="/z/d/html/808.html" rel="external">"Diagnostic evaluation of suspected breast cancer"</a>.)</p><p class="headingAnchor" id="H1976405553"><span class="h2">Chest wall</span><span class="headingEndMark"> — </span>Physical examination should also aim at differentiating true breast pain from extramammary pain. Features of breast pain that suggest an extramammary origin include [<a href="#rid9">9</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Unilateral, and brought on by activity</p><p class="bulletIndent1"><span class="glyph">●</span>Located very lateral or medial in the breast</p><p class="bulletIndent1"><span class="glyph">●</span>Reproducible by pressure on a specific area of the chest wall</p><p></p><p>To specifically look for chest wall pain, women may be asked to lie on each side. These positions enable the breast to fall away from the chest wall, which permits palpation of the underlying chest wall muscles and ribs. Women with pain in the lower aspect of their breast should have the breast elevated with one hand and the underlying chest wall palpated with the other [<a href="#rid9">9</a>]. </p><p>Chest wall pain due to pectoralis major muscle injury can be reproduced by asking the patient to place her hand flat on the iliac wing and push inward.</p><p>Women found to have chest wall pain can be reassured that there is no serious underlying cause for the pain, and they can be treated according to the symptoms. (See <a class="local">'Chest wall pain'</a> below.)</p><p class="headingAnchor" id="H10"><span class="h1">IMAGING</span><span class="headingEndMark"> — </span>For most women who present with breast pain, a thorough history and physical examination must be performed, and clinical judgment must be used in deciding upon any diagnostic imaging studies  (<a class="graphic graphic_algorithm graphicRef117756" href="/z/d/graphic/117756.html" rel="external">algorithm 1</a>). </p><p class="headingAnchor" id="H2289686178"><span class="h2">Suspicious physical findings present</span><span class="headingEndMark"> — </span>Women of any age who have suspicious physical findings such as a mass, skin changes, or bloody nipple discharge should undergo mammography with or without ultrasound. These patients should be clinically evaluated to exclude breast cancer, which is beyond the scope of this discussion. (See  <a class="medical medical_review" href="/z/d/html/808.html" rel="external">"Diagnostic evaluation of suspected breast cancer"</a>.)</p><p class="headingAnchor" id="H1875956771"><span class="h2">Suspicious physical findings absent</span><span class="headingEndMark"> — </span>Assuming they are up to date with breast cancer screening (see  <a class="medical medical_review" href="/z/d/html/7564.html" rel="external">"Screening for breast cancer: Strategies and recommendations"</a>), women who have breast pain but no other suspicious findings on physical examination may undergo breast imaging selectively based on their presentation and age. Breast imaging, even with a negative result, has been credited with alleviating patient anxiety. Seeking reassurance is often cited as the main reason for imaging in patients with breast pain [<a href="#rid21">21</a>]. Many women do not seek further medical attention after assurance that their pain is not due to breast cancer [<a href="#rid22">22</a>]. However, there is also evidence that imaging does not always provide such assurance [<a href="#rid23">23</a>]. </p><p>The imaging modalities most commonly used in these clinical scenarios are breast ultrasound and mammography. There are no data to suggest the use of breast magnetic resonance imaging (MRI) for this patient population. (See  <a class="medical medical_review" href="/z/d/html/7561.html" rel="external">"Breast imaging for cancer screening: Mammography and ultrasonography"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>In a case-control study, there was no difference in breast cancer incidence in women undergoing mammography for a painful breast (0.5 percent) compared with the contralateral nonpainful breast (0.5 percent) and compared with women without breast pain (0.7 percent) [<a href="#rid21">21</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Three studies of ultrasound for focal breast pain without a palpable mass detected cancer in 0 [<a href="#rid24">24</a>], 1.2 [<a href="#rid25">25</a>], and 4.6 percent of patients [<a href="#rid26">26</a>]. In the last study, only one-half of the cancers were detected at the site of the pain.</p><p></p><p>The American College of Radiology Appropriateness Criteria guidelines recommend the following approach to selecting an imaging modality [<a href="#rid27">27</a>]: </p><p class="bulletIndent1"><span class="glyph">●</span>Women with cyclical or bilateral nonfocal breast pain usually do not require imaging [<a href="#rid28">28,29</a>]; the yield of finding a specific cause with imaging is low. In a retrospective study of over 900 women who underwent breast imaging for isolated breast pain, cancer was detected in only 0.6 percent of average-risk patients, comparable to the expected incidence of 0.5 percent for screening mammography [<a href="#rid30">30</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Women with noncyclical, unilateral, or focal breast pain that is not extramammary (eg, chest wall pain), as determined by physical examination, should undergo breast imaging to elucidate the underlying etiology and exclude breast cancer. The choice of imaging modality is based on age:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Women under 30 years of age should undergo ultrasound because it is more accurate than mammography for that age group [<a href="#rid31">31</a>]. Mammography is added if abnormality is found on the ultrasound and/or if a patient's history or risk status justifies the radiation exposure (eg, family history of premenopausal breast cancer). (See  <a class="medical medical_review" href="/z/d/html/792.html" rel="external">"Factors that modify breast cancer risk in women"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Women between 30 and 39 years of age should also undergo ultrasound, and unilateral or bilateral mammography should also be performed because in this age group some small cancers are found on mammography but not ultrasound.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Women age 40 and older should undergo both mammography and ultrasound. </p><p></p><p>For women who have breast pain but no abnormality on physical examination or imaging studies, the risk for breast cancer is low at approximately 0.5 percent [<a href="#rid32">32,33</a>]. Such patients can be treated supportively, as described in the next sections. Positive findings on imaging studies require appropriate follow-up (eg, biopsy). (See  <a class="medical medical_review" href="/z/d/html/796.html" rel="external">"Breast biopsy"</a>.)</p><p class="headingAnchor" id="H11"><span class="h1">TREATMENT</span><span class="headingEndMark"> — </span>After obtaining normal findings on clinical and imaging studies, reassurance is often all that is required. A simple assurance that the patient does not have breast cancer provides adequate relief for 78 to 85 percent of women [<a href="#rid19">19,22,34</a>]. Such patients would also benefit from a follow-up visit in two to three months to exclude or treat recurrent/persistent pain.</p><p>For some women, however, breast pain can cause problems with their activities of daily living. As an example, in a study of 1171 healthy premenopausal women, 11 percent reported moderate-to-severe pain that interfered with sexual activity (48 percent), physical activity (37 percent), social activity (12 percent), and school activity (8 percent) [<a href="#rid5">5,35</a>]. Consequently, these women required treatment for their breast pain. </p><p>Approximately 15 percent of women seen in the breast clinic for breast pain require treatment beyond simple reassurance. Breast pain is treated medically  (<a class="graphic graphic_algorithm graphicRef117756" href="/z/d/graphic/117756.html" rel="external">algorithm 1</a>). Breast surgery is <strong>not</strong> indicated to treat pain in the absence of any breast pathology. </p><p class="headingAnchor" id="H766126376"><span class="h2">First-line therapy</span><span class="headingEndMark"> — </span>First-line therapy for breast pain is conservative and typically includes reassurance that this is not a malignancy, physical support, over-the-counter analgesics, and manipulation of hormone-based medications for those who take them. It is typically safe but may not be effective. We prefer to treat with first-line therapy for six months before moving onto one of the second-line therapies, which may be more effective but also have more side effects. Some practitioners also endorse therapies such as caffeine abstinence, smoking cessation, or evening primrose oil (EPO). Although such therapies have not been proven effective by placebo-controlled trials, they are generally harmless and may provide relief for some patients. (See <a class="local">'Therapies not proven by randomized trial data'</a> below.)</p><p class="headingAnchor" id="H13"><span class="h3">Physical support</span></p><p class="bulletIndent1"><span class="glyph">●</span>Support garments – A well-fitting brassiere to better support the breast is widely advocated [<a href="#rid36">36</a>]. The use of a support bra with steel underwire tends to reduce mastalgia in women with pendulous breasts. In addition, use of a "sports bra" during exercise has been shown to reduce pain related to breast movement [<a href="#rid37">37,38</a>]. Wearing a soft, supportive bra at night stops the breast pulling down on the chest wall, supports tender breast tissues, and helps many women sleep [<a href="#rid9">9</a>]. Women with asymmetric breasts may benefit from specialized fitting to place extra padding on one side, which permits appropriate support of that side without overcompressing the contralateral side.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Compresses – Some women obtain relief from application of warm compresses or ice packs or gentle massage. For those who breast feed, ice packs are recommended during the obstructive (prebacterial) phase of puerperal mastitis to decrease milk production regionally and thereby relieve ductal intraluminal pressure and subsequent pain. (See  <a class="medical medical_review" href="/z/d/html/4996.html" rel="external">"Common problems of breastfeeding and weaning"</a> and  <a class="medical medical_review" href="/z/d/html/798.html" rel="external">"Lactational mastitis"</a>.)</p><p></p><p class="headingAnchor" id="H623973406"><span class="h3">Acetaminophen or NSAID</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">Acetaminophen</a> or a nonsteroidal anti-inflammatory drug (NSAID), or both, can be used to relieve breast pain [<a href="#rid19">19</a>]. </p><p>Topical NSAIDs may also be useful. While the weaker types of topical NSAID (eg, <a class="drug drug_general" data-topicid="8547" href="/z/d/drug information/8547.html" rel="external">ibuprofen</a> gel) may not be effective in relieving breast pain [<a href="#rid39">39</a>], data from randomized trials demonstrated significant improvement in those treated with <a class="drug drug_general" data-topicid="9348" href="/z/d/drug information/9348.html" rel="external">diclofenac</a> gel with minimal side effects [<a href="#rid40">40</a>]. </p><p>In the United States (US), two types of topical NSAIDs are available:</p><p class="bulletIndent1"><span class="glyph">●</span>Salicylate, the active ingredient in <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">aspirin</a>, is found in Aspercreme and Nuprin.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9348" href="/z/d/drug information/9348.html" rel="external">Diclofenac</a>, which has the same active ingredient as the oral NSAID, is available as a patch, gel, or topical solution [<a href="#rid41">41,42</a>].</p><p></p><p class="headingAnchor" id="H541246182"><span class="h2">Second-line therapy</span><span class="headingEndMark"> — </span>Treatment with one of the second-line therapies may be required in patients who still have breast pain that diminishes quality of life despite first-line therapy for six months. We prefer to use <a class="drug drug_general" data-topicid="9972" href="/z/d/drug information/9972.html" rel="external">tamoxifen</a> first because it has fewer side effect than <a class="drug drug_general" data-topicid="9321" href="/z/d/drug information/9321.html" rel="external">danazol</a> [<a href="#rid43">43</a>]. We prefer to treat with tamoxifen or danazol for one to three months, until either pain subsides or side effects increase.</p><p class="headingAnchor" id="H768743995"><span class="h3">Tamoxifen</span><span class="headingEndMark"> — </span>For patients with more severe mastalgia refractory to other treatments, <a class="drug drug_general" data-topicid="9972" href="/z/d/drug information/9972.html" rel="external">tamoxifen</a> can provide breast pain relief. A meta-analysis of three randomized trials found tamoxifen to be more effective in relieving breast pain than placebo (relative risk 1.92, 95% CI 1.42-2.58) [<a href="#rid43">43</a>]. Tamoxifen is effective at both doses of 20 mg daily and 10 mg daily, and the side effects are significantly reduced at the lower dose [<a href="#rid44">44</a>]. Thus, when used off-label to treat severe mastalgia, tamoxifen is usually given at 10 mg once daily for three months. </p><p>However, <a class="drug drug_general" data-topicid="9972" href="/z/d/drug information/9972.html" rel="external">tamoxifen</a> is associated with menopause-like symptoms such as hot flashes, vaginal dryness, joint pain, and leg cramps. It can also increase the risk of blood clots, strokes, uterine cancer, and cataracts. Thus, tamoxifen is infrequently used to treat mastalgia. Restricting tamoxifen to the luteal phase of the menstrual cycle has also been suggested to reduce side effects [<a href="#rid9">9</a>]. (See  <a class="medical medical_review" href="/z/d/html/764.html" rel="external">"Managing the side effects of tamoxifen and aromatase inhibitors"</a>.)</p><p class="headingAnchor" id="H2823604120"><span class="h3">Danazol</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="9321" href="/z/d/drug information/9321.html" rel="external">Danazol</a> is an androgen, and for severe mastalgia, it is usually given at 200 mg once daily. It should be noted that since 2018, the US Food and Drug Administration (FDA) <strong>no longer</strong> approves the use of danazol for the indication of fibrocystic breast disease. </p><p><a class="drug drug_general" data-topicid="9321" href="/z/d/drug information/9321.html" rel="external">Danazol</a> is effective in relieving breast pain and tenderness. According to a meta-analysis of four randomized trials against placebo, it resulted in a 20 point mean reduction in pain score on a visual analogue scale (VAS) of 0 to 100 [<a href="#rid43">43,45,46</a>]. </p><p>However, the use of <a class="drug drug_general" data-topicid="9321" href="/z/d/drug information/9321.html" rel="external">danazol</a> is limited by its androgenic effects. At the recommended dose of 200 mg daily, significant proportions of patients reported side effects such as weight gain (30 percent), menstrual irregularity (50 percent), deepening of the voice (10 percent), and hot flashes (10 percent) [<a href="#rid47">47</a>]. Restricting the use of danazol to the luteal phase of the menstrual cycle reduces the side effects without compromising its effectiveness [<a href="#rid45">45</a>]. </p><p class="headingAnchor" id="H1897090444"><span class="h2">Women on hormone-based medications</span><span class="headingEndMark"> — </span>Postmenopausal hormone therapy that causes breast pain should be decreased or discontinued if at all possible [<a href="#rid48">48</a>]. However, this should only be done if breast pain is intolerable and after discussing with the patient the risks and benefits or curtailing hormone replacement therapy. (See  <a class="medical medical_review" href="/z/d/html/7427.html" rel="external">"Menopausal hormone therapy: Benefits and risks"</a>.) </p><p>It is not clear whether oral contraceptives cause or relieve cyclical mastalgia [<a href="#rid47">47</a>]. Decreasing the dose of estrogen in an oral contraceptive regimen can be effective in controlling breast pain. In other studies, oral contraceptives can reduce breast pain severity and duration in some women with cyclical symptoms [<a href="#rid49">49,50</a>]. The impact of oral contraceptive pills on breast pain may largely depend on their compositions; alternatively, they may have different effects on different women. </p><p>Progestogens also improve breast pain symptoms in some women [<a href="#rid51">51,52</a>]. While oral [<a href="#rid53">53</a>] and topical (applied to the breast) progesterone [<a href="#rid54">54</a>] did not show benefit in randomized trials, a vaginal cream of micronized progesterone (4 g of vaginal cream containing 2.5% natural progesterone used from the 19<sup>th</sup> to the 25<sup>th</sup> day of the cycle for six cycles) reduced breast pain in 65 percent of women compared with 22 percent of controls in a trial [<a href="#rid55">55</a>]. </p><p class="headingAnchor" id="H140548543"><span class="h2">Therapies not proven by randomized trial data</span><span class="headingEndMark"> — </span>The role of diet and lifestyle in relieving cyclical breast pain is unclear, with a strong likelihood of a placebo response for many interventions. However, some practitioners feel that some of these treatments (eg, caffeine abstinence and EPO) are worth trying because they are generally harmless and may offer some women pain relief. </p><p class="bulletIndent1"><span class="glyph">●</span>A low-fat (15 percent of calories), high-complex-carbohydrate diet has been effective in some observational studies and small randomized trials [<a href="#rid7">7,19,56</a>]. However, the trials could not be blinded, which may invite a placebo effect. Additionally, such low-fat diets are difficult to maintain beyond a few weeks. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Elimination of caffeine has not been effective in controlled trials, although anecdotally it seems to be helpful in some women [<a href="#rid10">10-12</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>EPO or its active ingredient gamma linoleic acid (GLA) has been studied in multiple randomized trials of breast pain [<a href="#rid57">57</a>]. Despite early enthusiasm, neither has been shown to be effective beyond the placebo effect [<a href="#rid34">34,43</a>]. One study suggested that iron deficiency and hypothyroidism in those who do not respond to EPO should be treated, as they could negatively impact the efficacy of EPO [<a href="#rid58">58</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="10049" href="/z/d/drug information/10049.html" rel="external">Vitamin E</a> has been shown in multiple randomized trials to be no better than placebo in the treatment of benign breast disease [<a href="#rid59">59,60</a>], although, again, some women report benefit with its utilization.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9164" href="/z/d/drug information/9164.html" rel="external">Bromocriptine</a> is a dopamine agonist that inhibits prolactin release. Although bromocriptine is effective in relieving pain compared with placebo, it is less effective than <a class="drug drug_general" data-topicid="9321" href="/z/d/drug information/9321.html" rel="external">danazol</a>, and up to 80 percent of women develop side effects such as headaches and dizziness. Therefore, it is no longer used to treat breast pain [<a href="#rid9">9</a>]. Several other drugs that affect estrogen or prolactin secretion (including bromocriptine and other gonadotropin-releasing hormone [GnRH] agonists) have been studied but are not advocated for use in patients with severe mastalgia, because of unfavorable side effect profiles [<a href="#rid61">61,62</a>].</p><p></p><p class="headingAnchor" id="H3123946433"><span class="h2">Investigational therapies</span><span class="headingEndMark"> — </span>Because of the unfavorable side effect profiles of the medications currently used to treat mastalgia (eg, <a class="drug drug_general" data-topicid="9321" href="/z/d/drug information/9321.html" rel="external">danazol</a>, <a class="drug drug_general" data-topicid="9972" href="/z/d/drug information/9972.html" rel="external">tamoxifen</a>), there is great interest in developing natural (herbal) products that could relieve breast pain. However, the benefits of most of these products remain unproven due to a lack of vigorous testing in randomized trials. </p><p class="bulletIndent1"><span class="glyph">●</span>Phytoestrogens, such as genistein, isoflavones, and soy milk, have been investigated as treatments for breast pain. Soy milk has been tested against cow milk in a controlled trial, and although an improvement of symptoms was noted in 56 percent of test subjects versus 10 percent of controls, the trial was criticized for noncompliance due to the unpalatable taste of the soy milk.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Agnus castus, a fruit extract, has significantly lowered visual analogue pain scores against placebo in controlled trials and is well tolerated [<a href="#rid63">63</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><em>Matricaria chamomilla </em>(chamomile) extract has also improved cyclical breast pain on a visual analogue scale compared with placebo in a controlled trial [<a href="#rid64">64</a>].</p><p></p><p class="headingAnchor" id="H2562354695"><span class="h2">Chest wall pain</span><span class="headingEndMark"> — </span>For women diagnosed with chest wall pain, local heat and analgesics such as <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">acetaminophen</a> or NSAIDs may relieve pain, but most women do not require therapy beyond reassurance that the source of pain is muscle strain or articular. Patients should reduce or cease activities that brought on or aggravated their pain until the pain improves. (See <a class="local">'Extramammary pain'</a> above.)</p><p>In severe cases in which the pain is localized but not relieved by over-the-counter pain medications, a trigger point injection with a mixture of a local anesthetic and corticosteroid may bring relief for the patient and can be repeated as necessary [<a href="#rid9">9</a>]. </p><p class="headingAnchor" id="H15"><span class="h1">PROGNOSIS</span><span class="headingEndMark"> — </span>In general, mastalgia has a natural history of remission and relapse, evidenced by the fact that improvement is seen in as many as 40 percent of women receiving placebo in randomized trials [<a href="#rid47">47</a>]. The prognosis of women who have breast pain is variable and influenced by the age of onset of pain and whether pain is cyclical or noncyclical [<a href="#rid22">22</a>]. In one series, cyclical breast pain spontaneously resolved within three months of onset in 20 to 30 percent of women, but transient relapses were common [<a href="#rid65">65</a>]. In another series, noncyclical breast pain spontaneously resolved in 50 percent of patients [<a href="#rid66">66</a>]. Relief may be spontaneous or related to a hormonally mediated event, such as pregnancy or menopause [<a href="#rid22">22</a>].</p><p class="headingAnchor" id="H879441782"><span class="h1">ASSOCIATED CONDITIONS</span><span class="headingEndMark"> — </span>Breast pain is usually a symptom, not a diagnosis. Although most women who have breast pain will not have any associated conditions, some will, in which case their pain should be treated as a component of the associated condition.</p><p class="headingAnchor" id="H1384211833"><span class="h2">Premenstrual syndrome</span><span class="headingEndMark"> — </span>Premenstrual syndrome (PMS) is characterized by the presence of both physical and behavioral (including affective) symptoms that occur repetitively in the second half of the menstrual cycle and interfere with some aspects of the woman's life. Breast tenderness is one of the common symptoms of PMS. A meta-analysis of 10 randomized trials of selective serotonin reuptake inhibitors (SSRIs) used in women with premenstrual symptoms showed SSRIs to be more effective than placebo at relieving breast pain [<a href="#rid67">67</a>]. Thus, women who have breast pain or tenderness as a component of PMS may benefit from SSRIs. (See  <a class="medical medical_review" href="/z/d/html/7382.html" rel="external">"Treatment of premenstrual syndrome and premenstrual dysphoric disorder", section on 'Selective serotonin reuptake inhibitors'</a>.)</p><p class="headingAnchor" id="H963943572"><span class="h2">Breast cancer</span><span class="headingEndMark"> — </span>As stated above, the presence of a breast cancer in a patient who presents with only pain is extremely low, ranging from 0.5 to 3.3 percent [<a href="#rid19">19,21,25,68-70</a>]. Breast pain may occur at the time of presentation of a breast cancer, although the pain is typically associated with adjacent benign, cystic breast tissue rather than the cancer. One caveat in retrospective studies is that recall of breast pain might be increased after the diagnosis of breast cancer. In addition, pain may also occur following the imaging and core biopsy of the cancer rather than being associated with the cancer itself. </p><p class="headingAnchor" id="H3510229230"><span class="h2">Prior breast surgery</span><span class="headingEndMark"> — </span>Pain that develops after breast surgery is of a different etiology and treated differently from de novo breast pain. It is discussed in other topics. (See  <a class="medical medical_review" href="/z/d/html/14973.html" rel="external">"Clinical manifestations and diagnosis of postmastectomy pain syndrome"</a> and  <a class="medical medical_review" href="/z/d/html/86609.html" rel="external">"Postmastectomy pain syndrome: Risk reduction and management"</a>.)</p><p class="headingAnchor" id="H281281168"><span class="h1">MALE BREAST PAIN</span><span class="headingEndMark"> — </span>Breast pain in men is usually due to gynecomastia. The causes and management of gynecomastia are discussed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/7476.html" rel="external">"Clinical features, diagnosis, and evaluation of gynecomastia in adults"</a> and  <a class="medical medical_review" href="/z/d/html/7467.html" rel="external">"Management of gynecomastia"</a> and  <a class="medical medical_review" href="/z/d/html/7466.html" rel="external">"Epidemiology, pathophysiology, and causes of gynecomastia"</a> and  <a class="medical medical_patient" href="/z/d/html/2186.html" rel="external">"Patient education: Gynecomastia (breast enlargement in males) (Beyond the Basics)"</a>.)</p><p class="headingAnchor" id="H953686085"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/121714.html" rel="external">"Society guideline links: Evaluation of breast problems"</a>.)</p><p class="headingAnchor" id="H16"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/z/d/html/16170.html" rel="external">"Patient education: Common breast problems (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/z/d/html/8395.html" rel="external">"Patient education: Common breast problems (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H17"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong> – Breast pain (mastalgia) is common in women but rarely a symptom of breast cancer in the absence of corroborating physical or imaging findings. The risk of having a breast cancer in a patient who presents with only breast pain is extremely low, ranging from 0.5 to 3.3 percent. This risk is no higher than that of a woman without breast pain. (See <a class="local">'Introduction'</a> above and <a class="local">'Epidemiology'</a> above and <a class="local">'Breast cancer'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Etiologies</strong> – Breast pain is classified as cyclical, noncyclical, or extramammary. Clinically it is more important to distinguish extramammary pain from true breast pain, as cyclical and noncyclical breast pain are treated similarly. (See <a class="local">'Classification and etiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation</strong> – Women who present with breast pain should undergo a thorough history and physical examination before clinical judgment is used to determine whether imaging tests are necessary  (<a class="graphic graphic_algorithm graphicRef117756" href="/z/d/graphic/117756.html" rel="external">algorithm 1</a>). (See <a class="local">'History'</a> above and <a class="local">'Physical examination'</a> above.)</p><p></p><p class="bulletIndent1">Assuming they are up to date with breast cancer screening (see  <a class="medical medical_review" href="/z/d/html/7564.html" rel="external">"Screening for breast cancer: Strategies and recommendations"</a>), women who have breast pain but lack suspicious findings on physical examination (eg, mass, skin changes, or bloody nipple discharge) may undergo breast imaging selectively based on their presentation and age (see <a class="local">'Imaging'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Cyclical or bilateral diffuse breast pain usually does not require imaging.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Noncyclical, unilateral, or focal breast pain that is not extramammary may benefit from breast imaging to elucidate the underlying etiology and exclude breast cancer. Women under 30 years of age should undergo ultrasound, those between 30 and 39 should undergo ultrasound with or without mammography, and those 40 or over should undergo both ultrasound and mammography.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment</strong> – Assurance that the patient does not have breast cancer provides adequate relief for up to 85 percent of women who present with breast pain; 15 percent require further treatment due to pain interfering with daily living. </p><p></p><p class="bulletIndent1">Breast pain is treated medically; surgery is not indicated in the absence of breast pathology. (See <a class="local">'Treatment'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>As first-line treatment for breast pain, we suggest conservative measures including physical support, <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">acetaminophen</a>, and/or nonsteroidal anti-inflammatory drugs (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). (See <a class="local">'First-line therapy'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For women with mastalgia refractory to six months of conservative treatment, we suggest <a class="drug drug_general" data-topicid="9972" href="/z/d/drug information/9972.html" rel="external">tamoxifen</a> rather than <a class="drug drug_general" data-topicid="9321" href="/z/d/drug information/9321.html" rel="external">danazol</a> (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). Patients should be informed of the significant side effects expected of both medications and be included in the decision-making process. While both medications have shown efficacy in reducing breast pain, danazol is associated with androgenizing effects. We prefer to administer either medication only during the luteal phase to minimize adverse effects. We typically treat for one to three months with either medication until either pain subsides or side effects increase. (See <a class="local">'Second-line therapy'</a> above.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Postmenopausal hormone therapy should be decreased or discontinued if possible after discussion with the patient. Although it is not clear whether oral contraceptives cause or relieve cyclical mastalgia, decreasing the dose of estrogen in an oral contraceptive regimen can be effective in controlling breast pain. (See <a class="local">'Women on hormone-based medications'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Although therapies such as caffeine abstinence and evening primrose oil have not been proven effective by vigorous placebo-controlled trials, some practitioners believe they may be tried because these treatments are generally harmless and may relieve pain in some patients. (See <a class="local">'Therapies not proven by randomized trial data'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prognosis</strong> – In general, mastalgia has a natural history of remission and relapse. The prognosis is variable and influenced by the age of onset of pain and whether pain is cyclical or noncyclical. Relief may be spontaneous or related to a hormonally mediated event, such as pregnancy or menopause. (See <a class="local">'Prognosis'</a> above.)</p><p></p><p class="headingAnchor" id="H816835303"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The editorial staff at UpToDate acknowledge Dirk Iglehart, MD, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Ader DN, Shriver CD. Cyclical mastalgia: prevalence and impact in an outpatient breast clinic sample. J Am Coll Surg 1997; 185:466.</a></li><li><a class="nounderline abstract_t">Love SM, Gelman RS, Silen W. Sounding board. Fibrocystic "disease" of the breast--a nondisease? N Engl J Med 1982; 307:1010.</a></li><li><a class="nounderline abstract_t">Devitt JE. Abandoning fibrocystic disease of the breast: timely end of an era. CMAJ 1986; 134:217.</a></li><li><a class="nounderline abstract_t">Hutter RV. Goodbye to "fibrocystic disease". N Engl J Med 1985; 312:179.</a></li><li><a class="nounderline abstract_t">Ader DN, South-Paul J, Adera T, Deuster PA. Cyclical mastalgia: prevalence and associated health and behavioral factors. J Psychosom Obstet Gynaecol 2001; 22:71.</a></li><li><a class="nounderline abstract_t">Scurr J, Hedger W, Morris P, Brown N. The prevalence, severity, and impact of breast pain in the general population. Breast J 2014; 20:508.</a></li><li><a class="nounderline abstract_t">Goodwin PJ, Miller A, Del Giudice ME, et al. Elevated high-density lipoprotein cholesterol and dietary fat intake in women with cyclic mastopathy. Am J Obstet Gynecol 1998; 179:430.</a></li><li><a class="nounderline abstract_t">Davies EL, Gateley CA, Miers M, Mansel RE. The long-term course of mastalgia. J R Soc Med 1998; 91:462.</a></li><li><a class="nounderline abstract_t">Iddon J, Dixon JM. Mastalgia. BMJ 2013; 347:f3288.</a></li><li><a class="nounderline abstract_t">Levinson W, Dunn PM. Nonassociation of caffeine and fibrocystic breast disease. Arch Intern Med 1986; 146:1773.</a></li><li><a class="nounderline abstract_t">Jacobson MF, Liebman BF. Caffeine and benign breast disease. JAMA 1986; 255:1438.</a></li><li><a class="nounderline abstract_t">Heyden S, Muhlbaier LH. Prospective study of "fibrocystic breast disease" and caffeine consumption. Surgery 1984; 96:479.</a></li><li><a class="nounderline abstract_t">Minton JP, Foecking MK, Webster DJ, Matthews RH. Caffeine, cyclic nucleotides, and breast disease. Surgery 1979; 86:105.</a></li><li><a class="nounderline abstract_t">Abraham GE. Nutritional factors in the etiology of the premenstrual tension syndromes. J Reprod Med 1983; 28:446.</a></li><li><a class="nounderline abstract_t">Archer DR, Fischer LA, Rich D, et al. Estrace vs Premarin for treatment of menopausal symptoms: dosage comparison study. Advances in Therapy 1992; 9:21.</a></li><li><a class="nounderline abstract_t">Bech P, Munk-Jensen N, Obel EB, et al. Combined versus sequential hormonal replacement therapy: a double-blind, placebo-controlled study on quality of life-related outcome measures. Psychother Psychosom 1998; 67:259.</a></li><li><a class="nounderline abstract_t">Greendale GA, Reboussin BA, Hogan P, et al. Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial. Obstet Gynecol 1998; 92:982.</a></li><li><a class="nounderline abstract_t">Peters F, Diemer P, Mecks O, Behnken L LJ. Severity of mastalgia in relation to milk duct dilatation. Obstet Gynecol 2003; 101:54.</a></li><li><a class="nounderline abstract_t">Smith RL, Pruthi S, Fitzpatrick LA. Evaluation and management of breast pain. Mayo Clin Proc 2004; 79:353.</a></li><li><a class="nounderline abstract_t">Morley JE, Dawson M, Hodgkinson H, Kalk WJ. Galactorrhea and hyperprolactinemia associated with chest wall injury. J Clin Endocrinol Metab 1977; 45:931.</a></li><li><a class="nounderline abstract_t">Duijm LE, Guit GL, Hendriks JH, et al. Value of breast imaging in women with painful breasts: observational follow up study. BMJ 1998; 317:1492.</a></li><li><a class="nounderline abstract_t">Wisbey JR, Kumar S, Mansel RE, et al. Natural history of breast pain. Lancet 1983; 2:672.</a></li><li><a class="nounderline abstract_t">Howard MB, Battaglia T, Prout M, Freund K. The effect of imaging on the clinical management of breast pain. J Gen Intern Med 2012; 27:817.</a></li><li><a class="nounderline abstract_t">Leung JW, Kornguth PJ, Gotway MB. Utility of targeted sonography in the evaluation of focal breast pain. J Ultrasound Med 2002; 21:521.</a></li><li><a class="nounderline abstract_t">Leddy R, Irshad A, Zerwas E, et al. Role of breast ultrasound and mammography in evaluating patients presenting with focal breast pain in the absence of a palpable lump. Breast J 2013; 19:582.</a></li><li><a class="nounderline abstract_t">Tumyan L, Hoyt AC, Bassett LW. Negative predictive value of sonography and mammography in patients with focal breast pain. Breast J 2005; 11:333.</a></li><li><a class="nounderline abstract_t">Expert Panel on Breast Imaging:, Holbrook AI, Moy L, et al. ACR Appropriateness Criteria® Breast Pain. J Am Coll Radiol 2018; 15:S276.</a></li><li><a class="nounderline abstract_t">Morrow M. The evaluation of common breast problems. Am Fam Physician 2000; 61:2371.</a></li><li><a class="nounderline abstract_t">Bergstrom CP, Keshvani N, Conzen SD. Diagnostic Imaging for Breast Pain: A Teachable Moment. JAMA Intern Med 2020; 180:1363.</a></li><li><a class="nounderline abstract_t">Mohallem Fonseca M, Lamb LR, Verma R, et al. Breast pain and cancer: should we continue to work-up isolated breast pain? Breast Cancer Res Treat 2019; 177:619.</a></li><li><a class="nounderline abstract_t">Harper AP, Kelly-Fry E, Noe JS. Ultrasound breast imaging-the method of choice for examining the young patient. Ultrasound Med Biol 1981; 7:231.</a></li><li><a class="nounderline abstract_t">Preece PE, Mansel RE, Hughes LE. Mastalgia: psychoneurosis or organic disease? Br Med J 1978; 1:29.</a></li><li><a class="nounderline abstract_t">Jenkins PL, Jamil N, Gateley C, Mansel RE. Psychiatric illness in patients with severe treatment-resistant mastalgia. Gen Hosp Psychiatry 1993; 15:55.</a></li><li><a class="nounderline abstract_t">Groen JW, Grosfeld S, Wilschut JA, et al. Cyclic and non-cyclic breast-pain: A systematic review on pain reduction, side effects, and quality of life for various treatments. Eur J Obstet Gynecol Reprod Biol 2017; 219:74.</a></li><li><a class="nounderline abstract_t">Ader DN, Browne MW. Prevalence and impact of cyclic mastalgia in a United States clinic-based sample. Am J Obstet Gynecol 1997; 177:126.</a></li><li><a class="nounderline abstract_t">Wilson MC, Sellwood RA. Therapeutic value of a supporting brassière in mastodynia. Br Med J 1976; 2:90.</a></li><li><a class="nounderline abstract_t">Hadi MS. Sports Brassiere: Is It a Solution for Mastalgia? Breast J 2000; 6:407.</a></li><li><a class="nounderline abstract_t">Mason BR, Page KA, Fallon K. An analysis of movement and discomfort of the female breast during exercise and the effects of breast support in three cases. J Sci Med Sport 1999; 2:134.</a></li><li><a class="nounderline abstract_t">Irving AD, Morrison SL. Effectiveness of topical non-steroidal anti-inflammatory drugs in the management of breast pain. J R Coll Surg Edinb 1998; 43:158.</a></li><li><a class="nounderline abstract_t">Colak T, Ipek T, Kanik A, et al. Efficacy of topical nonsteroidal antiinflammatory drugs in mastalgia treatment. J Am Coll Surg 2003; 196:525.</a></li><li><a class="nounderline abstract_t">Diclofenac gel for osteoarthritis. Med Lett Drugs Ther 2008; 50:31.</a></li><li><a class="nounderline abstract_t">A diclofenac patch (Flector) for pain. Med Lett Drugs Ther 2008; 50:1.</a></li><li><a class="nounderline abstract_t">Srivastava A, Mansel RE, Arvind N, et al. Evidence-based management of Mastalgia: a meta-analysis of randomised trials. Breast 2007; 16:503.</a></li><li><a class="nounderline abstract_t">Fentiman IS, Caleffi M, Hamed H, Chaudary MA. Dosage and duration of tamoxifen treatment for mastalgia: a controlled trial. Br J Surg 1988; 75:845.</a></li><li><a class="nounderline abstract_t">O'Brien PM, Abukhalil IE. Randomized controlled trial of the management of premenstrual syndrome and premenstrual mastalgia using luteal phase-only danazol. Am J Obstet Gynecol 1999; 180:18.</a></li><li><a class="nounderline abstract_t">Gateley CA, Miers M, Mansel RE, Hughes LE. Drug treatments for mastalgia: 17 years experience in the Cardiff Mastalgia Clinic. J R Soc Med 1992; 85:12.</a></li><li><a class="nounderline abstract_t">Rosolowich V, Saettler E, Szuck B, BREAST DISEASE COMMITTEE. RETIRED: Mastalgia. J Obstet Gynaecol Can 2006; 28:49.</a></li><li><a class="nounderline abstract_t">Dixon JM. Hormone replacement therapy and the breast. BMJ 2001; 323:1381.</a></li><li><a class="nounderline abstract_t">Graham CA, Sherwin BB. A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive. J Psychosom Res 1992; 36:257.</a></li><li><a class="nounderline abstract_t">Bancroft J, Rennie D. The impact of oral contraceptives on the experience of perimenstrual mood, clumsiness, food craving and other symptoms. J Psychosom Res 1993; 37:195.</a></li><li><a class="nounderline abstract_t">Euhus DM, Uyehara C. Influence of parenteral progesterones on the prevalence and severity of mastalgia in premenopausal women: a multi-institutional cross-sectional study. J Am Coll Surg 1997; 184:596.</a></li><li><a class="nounderline abstract_t">Uzan S, Denis C, Pomi V, Varin C. Double-blind trial of promegestone (R 5020) and lynestrenol in the treatment of benign breast disease. Eur J Obstet Gynecol Reprod Biol 1992; 43:219.</a></li><li><a class="nounderline abstract_t">Maddox PR, Harrison BJ, Horobin JM, et al. A randomised controlled trial of medroxyprogesterone acetate in mastalgia. Ann R Coll Surg Engl 1990; 72:71.</a></li><li><a class="nounderline abstract_t">McFadyen IJ, Raab GM, Macintyre CC, Forrest AP. Progesterone cream for cyclic breast pain. BMJ 1989; 298:931.</a></li><li><a class="nounderline abstract_t">Nappi C, Affinito P, Di Carlo C, et al. Double-blind controlled trial of progesterone vaginal cream treatment for cyclical mastodynia in women with benign breast disease. J Endocrinol Invest 1992; 15:801.</a></li><li><a class="nounderline abstract_t">Boyd NF, McGuire V, Shannon P, et al. Effect of a low-fat high-carbohydrate diet on symptoms of cyclical mastopathy. Lancet 1988; 2:128.</a></li><li><a class="nounderline abstract_t">Blommers J, de Lange-De Klerk ES, Kuik DJ, et al. Evening primrose oil and fish oil for severe chronic mastalgia: a randomized, double-blind, controlled trial. Am J Obstet Gynecol 2002; 187:1389.</a></li><li><a class="nounderline abstract_t">Balci FL, Uras C, Feldman S. Clinical Factors Affecting the Therapeutic Efficacy of Evening Primrose Oil on Mastalgia. Ann Surg Oncol 2020; 27:4844.</a></li><li><a class="nounderline abstract_t">Ernster VL, Goodson WH 3rd, Hunt TK, et al. Vitamin E and benign breast "disease": a double-blind, randomized clinical trial. Surgery 1985; 97:490.</a></li><li><a class="nounderline abstract_t">Meyer EC, Sommers DK, Reitz CJ, Mentis H. Vitamin E and benign breast disease. Surgery 1990; 107:549.</a></li><li><a class="nounderline abstract_t">Parlati E, Polinari U, Salvi G, et al. Bromocriptine for treatment of benign breast disease. A double-blind clinical trial versus placebo. Acta Obstet Gynecol Scand 1987; 66:483.</a></li><li><a class="nounderline abstract_t">Sismondi P, Biglia N, Giai M, Defabiani E. GnRH analogs in benign breast disease and breast cancer chemoprevention. A challenge for the year 2000. Eur J Gynaecol Oncol 1994; 15:108.</a></li><li><a class="nounderline abstract_t">Cerqueira RO, Frey BN, Leclerc E, Brietzke E. Vitex agnus castus for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review. Arch Womens Ment Health 2017; 20:713.</a></li><li><a class="nounderline abstract_t">Saghafi N, Rhkhshandeh H, Pourmoghadam N, et al. Effectiveness of Matricaria chamomilla (chamomile) extract on pain control of cyclic mastalgia: a double-blind randomised controlled trial. J Obstet Gynaecol 2018; 38:81.</a></li><li><a class="nounderline abstract_t">Kumar S, Mansel RE, Scanlon MF, et al. Altered responses of prolactin, luteinizing hormone and follicle stimulating hormone secretion to thyrotrophin releasing hormone/gonadotrophin releasing hormone stimulation in cyclical mastalgia. Br J Surg 1984; 71:870.</a></li><li><a class="nounderline abstract_t">Gateley CA, Mansel RE. Management of the painful and nodular breast. Br Med Bull 1991; 47:284.</a></li><li><a class="nounderline abstract_t">Marjoribanks J, Brown J, O'Brien PM, Wyatt K. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev 2013; :CD001396.</a></li><li><a class="nounderline abstract_t">Goodwin PJ, DeBoer G, Clark RM, et al. Cyclical mastopathy and premenopausal breast cancer risk. Results of a case-control study. Breast Cancer Res Treat 1995; 33:63.</a></li><li><a class="nounderline abstract_t">Plu-Bureau G, Thalabard JC, Sitruk-Ware R, et al. Cyclical mastalgia as a marker of breast cancer susceptibility: results of a case-control study among French women. Br J Cancer 1992; 65:945.</a></li><li><a class="nounderline abstract_t">Aiello EJ, Buist DS, White E, et al. Rate of breast cancer diagnoses among postmenopausal women with self-reported breast symptoms. J Am Board Fam Pract 2004; 17:408.</a></li></ol></div><div id="topicVersionRevision">Topic 803 Version 28.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9358091" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Cyclical mastalgia: prevalence and impact in an outpatient breast clinic sample.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7110289" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Sounding board. Fibrocystic "disease" of the breast--a nondisease?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3942926" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Abandoning fibrocystic disease of the breast: timely end of an era.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3965938" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Goodbye to "fibrocystic disease".</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11446156" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Cyclical mastalgia: prevalence and associated health and behavioral factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25041468" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : The prevalence, severity, and impact of breast pain in the general population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9731849" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Elevated high-density lipoprotein cholesterol and dietary fat intake in women with cyclic mastopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9849515" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : The long-term course of mastalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24336097" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Mastalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3530165" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Nonassociation of caffeine and fibrocystic breast disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3951074" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Caffeine and benign breast disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6474353" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Prospective study of "fibrocystic breast disease" and caffeine consumption.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/222001" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Caffeine, cyclic nucleotides, and breast disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6684167" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Nutritional factors in the etiology of the premenstrual tension syndromes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Estrace vs Premarin for treatment of menopausal symptoms: dosage comparison study</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9693354" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Combined versus sequential hormonal replacement therapy: a double-blind, placebo-controlled study on quality of life-related outcome measures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9840563" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12517645" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Severity of mastalgia in relation to milk duct dilatation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15008609" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Evaluation and management of breast pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/562902" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Galactorrhea and hyperprolactinemia associated with chest wall injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9831579" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Value of breast imaging in women with painful breasts: observational follow up study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6136808" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Natural history of breast pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22331398" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : The effect of imaging on the clinical management of breast pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12008815" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Utility of targeted sonography in the evaluation of focal breast pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24011215" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Role of breast ultrasound and mammography in evaluating patients presenting with focal breast pain in the absence of a palpable lump.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16174154" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Negative predictive value of sonography and mammography in patients with focal breast pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30392596" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : ACR Appropriateness Criteria®Breast Pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10794579" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : The evaluation of common breast problems.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32804195" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Diagnostic Imaging for Breast Pain: A Teachable Moment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31309396" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Breast pain and cancer: should we continue to work-up isolated breast pain?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7268931" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Ultrasound breast imaging-the method of choice for examining the young patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/620138" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Mastalgia: psychoneurosis or organic disease?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8436286" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Psychiatric illness in patients with severe treatment-resistant mastalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29059585" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Cyclic and non-cyclic breast-pain: A systematic review on pain reduction, side effects, and quality of life for various treatments.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9240595" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Prevalence and impact of cyclic mastalgia in a United States clinic-based sample.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1276824" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Therapeutic value of a supporting brassière in mastodynia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11348400" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Sports Brassiere: Is It a Solution for Mastalgia?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10476977" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : An analysis of movement and discomfort of the female breast during exercise and the effects of breast support in three cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9654874" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Effectiveness of topical non-steroidal anti-inflammatory drugs in the management of breast pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12691925" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Efficacy of topical nonsteroidal antiinflammatory drugs in mastalgia treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18425055" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Diclofenac gel for osteoarthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18197161" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : A diclofenac patch (Flector) for pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17509880" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Evidence-based management of Mastalgia: a meta-analysis of randomised trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3052691" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Dosage and duration of tamoxifen treatment for mastalgia: a controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9914571" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Randomized controlled trial of the management of premenstrual syndrome and premenstrual mastalgia using luteal phase-only danazol.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1548647" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Drug treatments for mastalgia: 17 years experience in the Cardiff Mastalgia Clinic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16533457" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : RETIRED: Mastalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11744551" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Hormone replacement therapy and the breast.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1564678" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8463994" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : The impact of oral contraceptives on the experience of perimenstrual mood, clumsiness, food craving and other symptoms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9179116" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Influence of parenteral progesterones on the prevalence and severity of mastalgia in premenopausal women: a multi-institutional cross-sectional study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1563574" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Double-blind trial of promegestone (R 5020) and lynestrenol in the treatment of benign breast disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2139769" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : A randomised controlled trial of medroxyprogesterone acetate in mastalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2497864" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Progesterone cream for cyclic breast pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1291593" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Double-blind controlled trial of progesterone vaginal cream treatment for cyclical mastodynia in women with benign breast disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2899188" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Effect of a low-fat high-carbohydrate diet on symptoms of cyclical mastopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12439536" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Evening primrose oil and fish oil for severe chronic mastalgia: a randomized, double-blind, controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32748152" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Clinical Factors Affecting the Therapeutic Efficacy of Evening Primrose Oil on Mastalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3885456" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Vitamin E and benign breast "disease": a double-blind, randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2185569" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Vitamin E and benign breast disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3321867" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Bromocriptine for treatment of benign breast disease. A double-blind clinical trial versus placebo.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8005138" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : GnRH analogs in benign breast disease and breast cancer chemoprevention. A challenge for the year 2000.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29063202" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Vitex agnus castus for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29072514" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Effectiveness of Matricaria chamomilla (chamomile) extract on pain control of cyclic mastalgia: a double-blind randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6437468" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Altered responses of prolactin, luteinizing hormone and follicle stimulating hormone secretion to thyrotrophin releasing hormone/gonadotrophin releasing hormone stimulation in cyclical mastalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1834299" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Management of the painful and nodular breast.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23744611" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Selective serotonin reuptake inhibitors for premenstrual syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7749134" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Cyclical mastopathy and premenopausal breast cancer risk. Results of a case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1616869" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Cyclical mastalgia as a marker of breast cancer susceptibility: results of a case-control study among French women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15575032" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Rate of breast cancer diagnoses among postmenopausal women with self-reported breast symptoms.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
